Formula Finance by Mark JC Nuijten.

info

Mission statement of hv4: to stimulate innovation in healthcare in order to increase the quality of life and well-being of all people on earth.

Objective: to optimise return on investment in health care innovation. hv4 (Healthcare Valuation 4) is pursuing the development of financial modelling and broadening their application in the field of economic valuation of innovative health care with a focus on biotechnology. read more

An example is the development of a financial valuation algorithm for the assessment of the futures sales of a new, innovative medicinal product. hv4 has also been successful in developing other challenging applications for models: pricing matrix model, pharmacoeconomic program development, portfolio investment, pricing strategy, communication strategy to stakeholders.

Notes

hv4 presents new financial valuation algorithm at Global Biotechnology Congress (July 22, 2015)

Dr. Mark Nuijten, founder of hv4, is speaker on July 22 at the Global Biotechnology Congress in Boston (United States). Mark Nuijten will present a financial valuation algorithm for the assessment of the futures sales of a new, innovative medicinal product based on the current reimbursement policies and future business models for reimbursement.